Heterogeneity of calcium channels in mast cells and basophils and the possible relevance to pathophysiology of lung diseases: A review

Agents and Actions

Volumn 17, Issue 5-6, 1986, Pages 407-417

  Chand, N ^a   Perhach Jr , J L ^a   Diamantis, W ^a   Sofia, R D ^a  

^a Wallace Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4,5 TRIMETHOXYBENZOIC ACID 8 (DIETHYLAMINO)OCTYL ESTER; BEPRIDIL; CALCIMYCIN; CALCIUM; CALCIUM ANTAGONIST; COMPOUND 48-80; CONCANAVALIN A; DANTROLENE; DILTIAZEM; GALLOPAMIL; LASALOCID; NIFEDIPINE; NIMODIPINE; VERAPAMIL;

BASOPHIL; BLOOD AND HEMOPOIETIC SYSTEM; CALCIUM CHANNEL; DRUG EFFICACY; DRUG THERAPY; ETIOLOGY; HUMAN; LUNG; LUNG DISEASE; MAST CELL; NONHUMAN; RABBIT; RAT; RESPIRATORY SYSTEM; REVIEW; SURVEY; THERAPY;

ANIMAL; BASOPHILS; CALCIUM; CALCIUM CHANNEL BLOCKERS; HISTAMINE RELEASE; HUMAN; ION CHANNELS; LEUKEMIA, EXPERIMENTAL; LUNG; LUNG DISEASES; MAST CELLS; MODELS, BIOLOGICAL; NEUTROPHILS; RABBITS; RATS;

EID: 0022591423     PISSN: 00654299     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/BF01965507     Document Type: Review

References (90)

1. The Pharmacological Control of Immediate Hypersensitivity
2. Calcium and Histamine Secretion from Mast Cells
3. Role of Calcium and Calcium Antagonists in Airway Function
4. Airway Hyperreactivity — Smooth Muscle and Calcium
5. Airways Smooth Muscle and Calcium Transport
6. Mechanisms of Histamine Release in Anaphylactic and Anaphylactoid Reactions
7. Calcium Channel Antagonists in Coronary Artery Spasm and Bronchial Spasm
8. Calcium, the Control of Smooth Muscle Function and Bronchial Hyperreactivity
9. Histamine Secretion from Mast Cells and Basophils
10. Calcium Hypersensitivity in Airways Smooth Muscle
11. Inhibition of Exercise-Induced Asthma by a Calcium Antagonist, Nifedipine
12. The Effect of Calcium Antagonist, Nifedipine, in Exercise-Induced Asthma
13. Nifedipine in the Prevention of Asthma Induced by Exercise and Histamine
14. A Calcium Antagonist, Nifedipine, Modifies Exercise-Induced Asthma
15. Effect of Calcium Antagonists on Allergen-Induced Asthma
16. Inhaled Verapamil in Histamine-Induced Bronchoconstriction
17. Nifedipine in Bronchial Asthma
18. The Effect of Verapamil on Histamine and Methacholine-Induced Bronchoconstriction
19. Effect of Verapamil in Obstructive Airways Disease
20. Inhibition of Airway Reactivity by Nifedipine in Patients with Coronary Artery Disease
21. The Effects of Nifedipine and Verapamil on Antigen-Induced Bronchoconstriction in Dogs
22. 2α and Histamine-Induced Bronchoconstriction in Anesthetized Dogs
23. Nifedipine Aerosol Attenuates Airway Constriction in Dogs with Hyperreactive Airways
24. Modification of Allergic Bronchoconstriction by a Calcium Antagonist: Mode of Action
25. Effects of Nifedipine on Antigen-Induced Bronchoconstriction
26. Inhibition of Bronchoconstriction in the Guinea Pig by a Calcium Channel Blocker Nifedipine
27. Effect of Calcium Antagonists in Experimental Asthma
28. Inhibitory Effects of Nifedipine on Allergic Reactions
29. Inhibitory Effect of Nifedipine and Cromolyn Sodium on Skin Reactions and 45Ca Uptake and Histamine Release in Rat Mast Cells Induced by Various Stimulating Agents
30. 2+ Antagonist Nifedipine on Histamine Release from Rat Peritoneal Mast Cells
31. Inhibition of Anaphylactic Histamine Release from Heterologously Sensitized Mast Cells: Differential Effects of Drugs Which Interfere with Calcium Influx
32. Histamine Release from Rat Mast Cells Sensitized with Mouse Antiserum
33. Dual Effect of Verapamil on Rat Peritoneal Mast Cells: Inhibition or Induction of Histamine Release
34. Anti-anaphylactic Properties of Verapamil. First Experimental Assessment
35. Inhibition of Allergic Histamine Secretion from Rat Peritoneal Mast Cells (RPMC) by Azelastine, a Novel, Orally Acting Antiallergic Agent
36. Calcium Ionophore A23187 as a Secretagogue for Rat Mast Cells: Does It Bypass Inhibition by Calcium Influx Blockers?
37. Calcium Antagonists and Histamine Secretion from Rat Peritoneal Mast Cells
38. Calcium Channel Blockers in Immediate Hypersensitivity
39. Stimulation and Inhibition of Histamine Release from Isolated Rat Mast Cells
40. Inhibition by Calcium Antagonists of Histamine Release and Calcium Influx of Rat Mast Cells: Difference Between Induction of Histamine Release by Concanavalin A and Compound 48/80
41. Effect of Inhibitors of Arachidonic Acid Metabolism Upon IgE and Non-IgE-Mediated Histamine Release
42. 2+ Antagonist Nifedipine on the Release of Platelet-Activating Factor (PAF-Acether), Slow-Reacting Substance and β-Glucuronidase from Human Neutrophils
43. Verapamil Inhibits Mediator Release from Human Lung In Vitro
44. Slow-Reacting-Substance (SRS) Release from Guinea Pig Lung: Inhibition by Calcium (Ca) Antagonists
45. Inhibition of Allergic and Nonallergic Histamine Secretion from Rat Peritoneal Mast Cells by Calcium Antagonists
46. 2+ Antagonist Nifedipine on Histamine and SRS Release from Human Lung Tissue
47. Inhibitory Effect of Calcium Antagonists on Histamine Release from Human Leukocytes
48. Interference of the Calcium Antagonists Verapamil and Nifedipine with Lysosomal Enzyme Release from Rabbit Polymorphonuclear Leukocytes
49. Effects of Smooth Muscle Calcium Antagonists on Human Basophil Histamine Release
50. Effect of Calcium Antagonists on Human Basophil Histamine Release
51. Arachidonic Acid Metabolism in Isolated Aorta and Lung of the Rat: Effects of Dipyridamole, Nifedipine, Propranolol, Hydralazine and Verapamil
52. Nifedipine Inhibition of Human Basophil Histamine Release
53. Nifedipine Protects Acetylcholine Induced Bronchoconstriction: The Role of Mediator Release
54. 2), Lipo-(LO), Cyclo (CO)-Oxygenase and Release of Platelet-Activating Factor (PAF) and Slow-Reacting Substance (SRS) from Rat Macrophages
55. 2 in Triggering Histamine Secretion from Human Basophils In Vitro
56. 2-Induced Rat Mast Cell Secretion. Role of Arachidonic Acid Metabolites
57. The Modulation of Human Basophil Histamine Release by Products of the 5-Lipoxygenase Pathway
58. Possible Role for the Products of Arachidonate-Lipoxygenase Pathway as Regulators of Airway Reactivity and Release of Chemical Mediators
59. Inhibition of the A-23187-Stimulated Leukotriene and Prostaglandin Biosynthesis of Rat Basophil Leukemia (RBL-1) Cells By Nonsteroidal Antiinflammatory Drugs, Anti-oxidants, and Calcium Channel Blockers
60. Inhibition of IgE-Mediated Allergic Histamine Release by Azelastine from Rabbit Basophils
61. Influenza A Virus Enhanced Basophilic Leukocyte Histamine Release: A Calcium Flux Defect
62. Inhibition of Human Basophil Histamine Release by the Calcium Channel Antagonists
63. Basophil Spontaneous Histamine Release
64. Influenza A Virus Enhancement of Human Basophilic Leukocyte Histamine Release
65. Inhibition of Rat Mast Degranulation by Verapamil
66. In Vitro Inhibition of Allergic Histamine Release by Calcium Antagonists
67. Calmodulin, Phospholipase and Exocytosis p-bromophenacylbromide Inhibits but Mepacrine Stimulates Secretion in Rat Mast Cells
68. Evaluation of Calcium Entry Blockers in Several Models of Immediate Hypersensitivity
69. Nifedipine — a Calcium Channel Blocker in Asthmatic Patients
70. Uptake of Calcium Antagonists Drugs into Muscles as Related to Their Lipid Solubilities
71. Bepridil and Flunarizine as Calmodulin Inhibitors
72. Full Spectrum Calcium Channel Blocking Agents. An Overview
73. Mast Cell Heterogeneity
74. Mast Cell Heterogeneity
75. Comparative Studies in Human Basophils and Mast Cells
76. Inhibition of Allergic Histamine Release by Azelastine and Selected Antiallergic Drugs from Rabbit Leukocytes
77. Inhibition of Allergic and Nonallergic Histamine Release (HR) by Azelastine (AZ) and Lipoxygenase Inhibitors (LI)
78. Inhibition of Calcium Ionophore (A23187)-Stimulated Histamine Release from Rat Peritoneal Mast Cells by Azelastine: Implications for its Mode of Action
79. Inhibition of IgE-Mediated Allergic Histamine Release from Rat Peritoneal Mast Cells by Azelastine and Selected Antiallergic Drugs
80. Inhibition by Azelastine of Nonallergic Histamine Release from Rat Peritoneal Mast Cells
81. Effect of Cyclic AMP, Disodium Cromoglycate and Other Antiallergic Drugs on Histamine Secretion from Rat Mast Cells Stimulated with the Calcium Ionophore Ionomycin
82. Inhibition of Calcium Ionophore (A23187)-Induced Histamine Release by A Novel Anti-allergic Agent, 4-(p-chlorobenzyl)-2-(Hexa-hdyrol-methyl-l H-azepine-4yl)-l(2H)-phthalazinone hydrochloride (azelastine; A5610)
83. In Vitro Model for Exercise (Cold)-Induced Asthma: I Experimental Details